Microbial Photoinactivation by Visible Light Results in Limited Loss of Membrane Integrity

Evaluation of visible light and natural photosensitizers against Staphylococcus epidermidis and Staphylococcus saprophyticus planktonic cells and biofilm

Antimicrobial photoinactivation (API) has shown some promise in potentially treating different nosocomial bacterial infections, however, its application on staphylococci, especially other than Staphylococcus aureus or methicillin-resistant S. aureus (MRSA) species is still limited. Although S. aureus is a well-known and important nosocomial pathogen, several other species of the genus, particularly coagulase-negative Staphylococcus (CNS) species such as Staphylococcus epidermidis and Staphylococcus saprophyticus, can also cause healthcare-associated infections and foodborne intoxications. CNS are often involved in resilient biofilm formation on medical devices and can cause infections in patients with compromised immune systems or those undergoing invasive procedures. In this study, the effects of chlorophyllin and riboflavin-mediated API on S. epidermidis and S. saprophyticus planktonic cells and biofilm are demonstrated for the first time. Based on the residual growth determination and metabolic reduction ability changes, higher inactivating efficiency of chlorophyllin-mediated API was determined against the planktonic cells of both tested species of bacteria and against S. saprophyticus biofilm. Some insights on whether aqueous solutions of riboflavin and chlorophyllin, when illuminated with optimal exciting wavelength (440 nm and 402 nm, respectively) generate O2-•, are also provided in this work.

The dynamics and removal efficiency of antibiotic resistance genes by UV-LED treatment: An integrated research on single- or dual-wavelength irradiation

Antimicrobial resistance has gained increasing attention, because of the awareness of its potential health risks. Strategies for the removal of antibiotic resistance genes (ARGs) are urgently required. In the present study, UV-LEDs at wavelength of 265 and 285 nm were integrated at five conditions, including single 265 nm UV-LED, single 285 nm UV-LED, and combined 265 nm and 285 nm UV-LED at different intensities, to remove tet A, cat 1, and amp C. The ARGs removal efficiency, gene behavior, and possible cellular mechanism were analyzed using real-time quantitative PCR, flow cytometry, and transmission electron microscopy (TEM). The 265 nm UV-LED is more effective than the 285 nm UV-LED and their combinations in terms of ARGs control, in which 1.91, 1.71, and 1.45 log were removed for tet A, cat 1, and amp C, respectively, at a UV dosage of 500 mJ/cm2. The intracellular gene leakage was detected in all five UV-LED experiment scenarios even when the cell membrane damage was insignificant with the highest increase of 0.69 log ARGs. ROS was generated during the irradiation, and the ROS was strongly negative correlated with intracellular ARGs, which could promote the degradation and removal of ARGs. This study provides a new insight of intracellular ARGs removal, because direct irradiation, ROS oxidation, and leakage to the extracellular serve as the three main pathways under high-dosage UV-LED irradiation. Further research should be focused on the mechanism and optimization of UV technology with 265 nm UV-LED for ARG control.

New Insights into the Bacterial Targets of Antimicrobial Blue Light

Antimicrobial blue light (aBL) offers efficacy and safety in treating infections. However, the bacterial targets for aBL are still poorly understood and may be dependent on bacterial species. Here, we investigated the biological targets of bacterial killing by aBL (λ = 410 nm) on three pathogens: Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Initially, we evaluated the killing kinetics of bacteria exposed to aBL and used this information to calculate the lethal doses (LD) responsible for killing 90 and 99.9% of bacteria. We also quantified endogenous porphyrins and assessed their spatial distribution. We then quantified and suppressed reactive oxygen species (ROS) production in bacteria to investigate their role in bacterial killing by aBL. We also assessed aBL-induced DNA damage, protein carbonylation, lipid peroxidation, and membrane permeability in bacteria. Our data showed that P. aeruginosa was more susceptible to aBL (LD99.9 = 54.7 J/cm2) relative to S. aureus (LD99.9 = 158.9 J/cm2) and E. coli (LD99.9 = 195 J/cm2). P. aeruginosa exhibited the highest concentration of endogenous porphyrins and level of ROS production relative to the other species. However, unlike other species, DNA degradation was not observed in P. aeruginosa. Sublethal doses of blue light (LD99.9). We conclude that the primary targets of aBL depend on the species, which are probably driven by variable antioxidant and DNA-repair mechanisms. IMPORTANCE Antimicrobial-drug development is facing increased scrutiny following the worldwide antibiotic crisis. Scientists across the world have recognized the urgent need for new antimicrobial therapies. In this sense, antimicrobial blue light (aBL) is a promising option due to its antimicrobial properties. Although aBL can damage different cell structures, the targets responsible for bacterial inactivation have still not been completely established and require further exploration. In our study, we conducted a thorough investigation to identify the possible aBL targets and gain insights into the bactericidal effects of aBL on three relevant pathogens: Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. This research not only adds new content to blue light studies but opens new perspectives to antimicrobial applications.

Photobiomodulation with Blue Light on Wound Healing: A Scoping Review

BACKGROUND

Photobiomodulation consists of inducing healing by irradiating light. This scoping review investigates the effect of blue light on the healing process.

METHODS

The MEDLINE, Web of Science, Scopus, and CINAHL databases were searched. Two reviewers independently examined the search results and extracted data from the included studies. A descriptive analysis was performed.

RESULTS

Twenty-two articles were included. Studies were categorized as in vitro/mixed, preclinical, and clinical. The power density used was 10-680 mW/cm² in most of the in vitro/preclinical studies, the irradiation time ranged from 5 s to 10 min, and different wavelengths and energy densities were used. In clinical studies, the wavelength ranged from 405 to 470 nm, and the energy density varied from 1.5 to 30 J/cm².

CONCLUSIONS

A low energy density (<20 J/cm²) was able to stimulate the different cell types and proteins involved in healing, while a high energy density, 20.6-50 J/cm², significantly reduced cell proliferation, migration, and metabolism. There is a great variety of device parameters among studies, and this makes it difficult to conclude what the best technical specifications are. Thus, further studies should be performed in order to define the appropriate parameters of light to be used.

Effectiveness of purple led for inactivation of Bacillus subtilis and Escherichia coli bacteria in in vitro sterilizers

Bacteria are inactivated using a technique called photodynamic inactivation, which combines light with a photosensitizer with the right spectrum. The objective of this study is to ascertain the e­ciency of purple LEDs for photoinactivating Bacillus subtilis and Escherichia coli bacteria as well as the ideal purple LED exposure energy density. This study technique involves exposing bacteria to purple LED radiation. Two elements of variation are used during irradiation. The first variation is the illumination variation at distances of 3 cm, 6 cm, 9 cm, and 12 cm. The second variation involves changing the amount of radiation for 30, 60, 90, and 120 minutes. The Total Plate Count (TPC) method was used to count the number of colonies. Statistical tests were utilized in data analysis, namely the One Way Anova test (analysis of variance). The results of this study indicated that 395 nm purple LED irradiation caused a decrease in Log CFU/mL of Bacillus subtilis and Escherichia coli bacteria. Inactivation of Bacillus subtilis bacteria showed a higher mortality percentage than Escherichia coli bacteria. Changes in other irradiation distances also showed a higher percentage of death for Bacillus subtilis bacteria than Escherichia coli bacteria. The highest percentage of death was 98.5% for Bacillus subtilis bacteria and 94.3% for Escherichia coli bacteria at position C with an irradiation distance of 3 cm and an energy density of 524 J/cm2 with an LED exposure time of 120 minutes. This shows that the percentage of death of bacteria Bacillus subtilis and Escherichia coli increased with increasing doses of LED energy with the greatest percentage of death in Gram-positive bacteria Bacillus subtilis.

Novel Semiconductor Cu(C3H3N3S3)3/ZnTiO3/TiO2 for the Photoinactivation of E. coli and S. aureus under Solar Light

The use of semiconductors for bacterial photoinactivation is a promising approach that has attracted great interest in wastewater remediation. The photoinactivator Cu-TTC/ZTO/TO was synthesized by the solvothermal method from the coordination complex Cu(C₃H₃N₃S₃)₃ (Cu-TTC) and the hybrid semiconductor ZnTiO₃/TiO₂ (ZTO/TO). In this study, the effect of photocatalyst composition/concentration as well as radiation intensity on the photoinactivation of the gram-negative bacteria Escherichia coli and the gram-positive bacteria Staphylococcus aureus in aqueous solutions was investigated. The results revealed that 25 mg/mL of photoinactivator, in a Cu-TTC:ZTO/TO molar ratio of 1:2 (w/w%) presents a higher rate of bacterial photoinactivation under simulated solar light (λ = 300-800 nm) in comparison to the individual components. The evidence of this study suggests that the presence of the Cu(C₃H₃N₃S₃)₃ coordination complex in the ZnTiO₃/TiO₂ hybrid semiconductor would contribute to the generation of reactive oxygen species (ROS) that are essential to initiate the bacterial photoinactivation process. Finally, the results obtained allow us to predict that the Cu-TTC/ZTO/TO photocatalyst could be used for effective bacterial inactivation of E. coli and S. aureus in aqueous systems under simulated solar light.

Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond?

Over the past decade, antimicrobial blue light (aBL) at 400 - 470 nm wavelength has demonstrated immense promise as an alternative approach for the treatment of multidrug-resistant infections. Since our last review was published in 2017, there have been numerous studies that have investigated aBL in terms of its, efficacy, safety, mechanism, and propensity for resistance development. In addition, researchers have looked at combinatorial approaches that exploit aBL and other traditional and non-traditional therapeutics. To that end, this review aims to update the findings from numerous studies that capitalize on the antimicrobial effects of aBL, with a focus on: efficacy of aBL against different microbes, identifying endogenous chromophores and targets of aBL, Resistance development to aBL, Safety of aBL against host cells, and Synergism of aBL with other agents. We will also discuss our perspective on the future of aBL.

The effects of violet and blue light irradiation on ESKAPE pathogens and human cells in presence of cell culture media

Bacteria belonging to the group of ESKAPE pathogens are responsible for the majority of nosocomial infections. Due to the increase of antibiotic resistance, alternative treatment strategies are of high clinical relevance. In this context visible light as disinfection technique represents an interesting option as microbial pathogens can be inactivated without adjuvants. However cytotoxic effects of visible light on host cells have also been reported. We compared the cytotoxicity of violet and blue light irradiation on monocytic THP-1 and alveolar epithelium A549 cells with the inactivation effect on ESKAPE pathogens. THP-1 cells displayed a higher susceptibility to irradiation than A549 cells with first cytotoxic effects occurring at 300 J cm⁻² (405 nm) and 400 J cm⁻² (450 nm) in comparison to 300 J cm⁻² and 1000 J cm⁻², respectively. We could define conditions in which a significant reduction of colony forming units for all ESKAPE pathogens, except Enterococcus faecium, was achieved at 405 nm while avoiding cytotoxicity. Irradiation at 450 nm demonstrated a more variable effect which was species and medium dependent. In summary a significant reduction of viable bacteria could be achieved at subtoxic irradiation doses, supporting a potential use of visible light as an antimicrobial agent in clinical settings.